Effect of solubilizing and microemulsifying excipients in polyethylene glycol 6000 solid dispersion on enhanced dissolution and bioavailability of ketoconazole

Archives of Pharmacal Research

Volumn 28, Issue 5, 2005, Pages 604-611

  Heo, Min Young ^a   Piao, Zong Zhu ^a   Kim, Tae Wan ^a   Cao, Qing Ri ^a   Kim, Aera ^a   Lee, Beom Jin ^a  

^a Kangwon National University   (South Korea)

Author keywords

Bioavailability; Crystal structure; Dissolution rate; Pharmaceutical excipients; Solid dispersion; Solubilizing and microemulsifying

Indexed keywords

EXCIPIENT; KETOCONAZOLE; MACROGOL DERIVATIVE;

ANIMAL; ARTICLE; BIOAVAILABILITY; CHEMISTRY; EMULSION; MALE; RAT; SOLUBILITY; SPRAGUE DAWLEY RAT;

ANIMALS; BIOLOGICAL AVAILABILITY; EMULSIONS; EXCIPIENTS; KETOCONAZOLE; MALE; POLYETHYLENE GLYCOLS; RATS; RATS, SPRAGUE-DAWLEY; SOLUBILITY;

EID: 23844542459     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/BF02977766     Document Type: Article

References (20)

1. Alden, M., Tegenfeldt, J., and Saers, E. S., Structures formed by interactions in solid dispersions of the system polyethylene glycol-griseofulvin with charged and noncharged surfactants added. Int. J. Pharm., 94, 31-38 (1993).
2. Attama, A. A., Nzekwe, I. T., Nnamani, P. O., Adikwu, M. Y., and Onugu, C. O., The use of solid self-emulsifying systems in the delivery of diclofenac. Int. J. Pharm., 262, 23-28 (2003).
3. Baxter, J. G., Brass, C., Schentag, J. J., and Slaughter, F. L., Pharmacokinetics of ketoconazole administered intravenously to dogs and orally as ablet and solution to humans and dogs. Pharm. Res., 75, 443-447 (1986).
4. Betageri, G. V. and Makarla, K. R., Characterization of glyburide-polyethylene glycol solid dispersions. Drug Dev. Ind. Pharm., 22, 731-734 (1996).
5. Caliph, S., Charman, W. N., and Porter, C. J. H., Effect of short-medium-and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats. J. Pharm. Sci., 89, 1073-1084 (2000).
6. Cao, Q.-R., Kim, T.-W., Choi, C.-Y., Kwon, K .A., and Lee, B.-J., Preparation and dissolution of PVP-based solid dispersion capsules containing solubilizers. J. Kor. Pharm. Sci., 33, 7-14 (2003).
7. Chiou, W. L. and Riegelman, S., Pharmaceutical applications of solid dispersion system. J. Pharm. Sci., 60, 1281-1302 (1971).
8. Constantinides, P. P., Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm. Res., 12, 1561-1572 (1995).
9. Cornaire, G., Woodley, J., Hermann, P., Cloarec, A., Arellano, C., and Houin, G., Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo. Int. J. Pharm., 278, 119-131 (2004).
10. Franco, M., Trapani, G., Latrofa, A., Tullio, C., Provenzano, M. R., Serra, M., Muggironi, M., Biggio, G., and Liso, G., Dissolution properties and anticonvulsant activity of phenytoinpolyethylene glycol 6000 and polyvinylpyrrolidone K-30 solid dispersions. Int. J. Pharm., 225, 63-73 (2001).
11. Joshi, H. N., Tejwani, R. W., Davidovich, M., Sahasrabudhe, V. P., Jemal, M., Bathala, M. S., Varia, S. A., and Serajuddin, T. M., Bioavailability enhancement of a poorly water-soluble drug by solid dispersion in polyethylene glycol-polysorbate 80 mixture. Int. J. Pharm., 269, 251-258 (2004).
12. Kim, T.-W., Choi, C.-Y., Cao, Q.-R., Kwon, K. A., and Lee, B.-J., Dissolution profiles of solid dispersions containing poorly water-soluble drugs and solubilizing compositions. J. Kor. Pharm. Sci., 32, 191-197 (2002).
13. Morris, K. R., Knipp, G. T., and Serajuddin, A. T. M., Structural properties of polyethylene glycol-polysorbate 80 mixture, a solid dispersion vehicle. J. Pharm. Sci., 81, 1185-1188 (1992).
14. Mura, P., manderioli, A., Bramanti, G., and Ceccareli, L., Properties of solid dispersions of naproxen in various polyethylene glycols. Drug Dev. Ind. Pharm., 22, 909-916 (1996).
15. Owusu-Ababio, G., Ebube, N. K., Reams, R., and Habib, M., Comparative dissolution studies for mefenamic acid-polyethylene glycol solid dispersion systems and tablets. Pharm. Dev. Technol., 3, 405-412 (1998).
16. Porter, C. J. H. and Charman, W. N., Intestinal lymphatic drug transport: an update. Adv. Drug Del. Rev., 50, 61-80 (2001).
17. Serajuddin, A. T. M., Solid dispersion of poorly water-soluble drugs: Early promises, subsquent problems, and recent breakthroughs. J. Pharm. Sci., 88, 1058-1066 (1999).
18. Sheen, P. C., Khetarpal, V. K., Cariola, C. M., and Rowlings, C. E., Formulation studies of a poorly water-soluble drug in solid dispersions to improve bioavailability. Int. J. Pharm., 118, 221-227 (1995).
19. Verheyen, S., Blaton, N., Kinget, R., and Mooter, G. V., Mechanism of increased dissolution of diazepam and temazepam from polyethylene glycol 6000 solid dispersions. Int. J. Pharm., 249, 45-58 (2002).
20. Wang, S.-W., Monagle, J., McNulty, C., Putnam, D., and Chen, H., Determination of P-glycoprotein inhibition by excipients and their combinations using an integrated high-throughput process. J. Pharm. Sci., 93, 2755-2767 (2004).